https://www.cancer.gov/about-cancer/treatment/drugs/momelotinib-dihydrochloride-monohydrate
Momelotinib Dihydrochloride Monohydrate - NCI
This page contains brief information about momelotinib dihydrochloride monohydrate and a collection of links to more information about the use of this drug,...
momelotinib dihydrochloridemonohydratenci
https://www.pharmaceutical-technology.com/data-insights/momelotinib-dihydrochloride-gsk-relapsed-acute-myeloid-leukemia-likelihood-of-approval/
Momelotinib dihydrochloride by GSK for Relapsed Acute Myeloid Leukemia: Likelihood of Approval
Dec 29, 2024 - Momelotinib dihydrochloride is under clinical development by GSK and currently in Phase II for Relapsed Acute Myeloid Leukemia.
acute myeloid leukemiamomelotinib dihydrochloride